Speaking of Mol Bio, a podcast series from Thermo Fisher Scientific, discusses trending applications in science and the molecular biology aspects of those applications. Our host delves in to deep discussion with CEOs, R&D scientists, researchers, and key opinion leaders across the globe. Speaking of Mol Bio helps scientific curious people - from all scientific and non-scientific backgrounds - understand how modern molecular biology applications can help push the boundaries in medicine, science, drug discovery, and in the cure and treatment of diseases.
Music from NOWHERE by ikson™ (https://www.iksonmusic.com)
All content for Speaking of Mol Bio is the property of Thermo Fisher Scientific and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Speaking of Mol Bio, a podcast series from Thermo Fisher Scientific, discusses trending applications in science and the molecular biology aspects of those applications. Our host delves in to deep discussion with CEOs, R&D scientists, researchers, and key opinion leaders across the globe. Speaking of Mol Bio helps scientific curious people - from all scientific and non-scientific backgrounds - understand how modern molecular biology applications can help push the boundaries in medicine, science, drug discovery, and in the cure and treatment of diseases.
Music from NOWHERE by ikson™ (https://www.iksonmusic.com)
Dr. Andre Ghetti, CEO of AnaBios, joins to discuss how his company helps de-risk drug development by using ethically sourced, functional human tissues to generate preclinical data. He shares how AnaBios bridges the translational gap between animal models and clinical trials through precision assays, AI-powered analytics, and validated human tissue platforms.
Dr. Agnė Alminaitė introduces Thermo Fisher Scientific’s new Dry-Ready™ reagent kits for RT-LAMP and RT-qPCR assays, offering room temperature stability without requiring lyophilization. She explains how these kits simplify workflows, reduce equipment needs, and help assay developers bring stable, reliable tests to market faster.
Dr. Felipe Gálvez-Cancino of Oxford University discusses how regulatory T cells suppress immune responses in cancer and how his lab is teaching macrophages to overcome those signals and phagocytose tumor cells. He shares insights from his journey through cancer vaccines, antibody engineering, and the fundamental biology of immune regulation.
Dr. Will Barnes shares insights from his years at the bench as a plant biologist, detailing the challenges of working with RNA and cDNA synthesis in difficult samples. He discusses how smarter reagent choices and thoughtful sample prep transformed his results and his perspective.
Dr. Melissa Wu, CEO of Seeding Labs, joins the show to share how her nonprofit is accelerating global science by connecting surplus lab equipment with researchers in under-resourced countries. From thermal cyclers to fume hoods, she explains how Seeding Labs is building institutional capacity and empowering scientific talent worldwide.
This Mol Bio Minutes episode features Thermo Fisher's Agnė Žiupkaitė diving into the evolving landscape of RT-qPCR assay development. She discusses enzyme customization, reagent formulation, and how choosing the right raw material supplier can significantly impact assay performance and commercialization success.
Giovanna Prout, CEO of Scale Biosciences, shares how her multidisciplinary background and entrepreneurial spirit drive the development of scalable, instrument-free single-cell omics solutions. She discusses the company’s core technology, quantum barcoding, and how Scale is enabling massive-scale experiments that fuel AI, drug screening, and precision medicine.
This episode dives into the principles and advantages of 1-Step RT-PCR, an efficient method that streamlines RNA detection into a single-tube process. Aistė Serapinaite explains how this technology saves time, reduces contamination risk, and offers high sensitivity for applications ranging from gene expression analysis to viral pathogen detection.
Dr. Beth Webb joins to discuss the fascinating complexity of platelets—tiny, nucleus-free powerhouses involved in clotting, immunity, and beyond. She shares insights from her research at the University of Leeds and reflects on the challenges and rewards of science communication.
Laurynas Alijošius returns to explore the many factors that influence PCR accuracy—and how to improve them. From enzyme fidelity to cycling conditions, he offers practical tips to reduce errors and streamline your workflow.
Dr. Cath Moore, CSO of AGRF, shares how molecular biology is powering innovation across healthcare, agriculture, conservation, and beyond. From genomics to proteomics and systems biology, this episode explores how Australia is embracing multiomic tools to solve complex real-world problems.
PCR, a high-speed alternative to standard thermocycling that saves both time and resources. From choosing the right instruments and consumables to optimizing enzymes and cycling conditions, this episode is your quick-start guide to faster PCR workflows.
In this episode of Speaking of Mol Bio, Dr. Gudrun Stengel, co-founder of Alida Biosciences, discusses the groundbreaking technology of proximity barcoding for RNA modifications. She shares insights into how this innovation could transform diagnostics, therapeutics, and synthetic biology, while offering valuable advice for aspiring scientists.
In this Mol Bio Minutes episode, Sune Lund Sporring of Thermo Fisher Scientific breaks down practical strategies for making labs more sustainable. From smarter energy use to second-generation bio-based plastics, learn how small steps can create big environmental impacts without disrupting your workflow.
Dr. Nadav Ahituv, Professor and Director of the Institute for Human Genetics at UCSF, takes us on a journey through groundbreaking work in gene regulation, disease genetics, and the evolution of bats. From high-throughput CRISPR screens to developing fat-based cancer therapies, his research is helping shape the future of personalized medicine and genetic treatments.
This third and final Mol Bio Minutes episode on the nucleic acid electrophoresis topic has Aistė Polikaitytė sharing a wealth of tips, tricks and resources to avoid and troubleshoot some of the most common gel separation and analysis issues.
Curious about the interface of AI, biology and chemistry? Join us for a look at how computationally informed biology is being applied to help solve environmental and biomanufacturing challenges involving chemistry.
In this second Mol Bio Minutes mini episode Paulius Palaima covers staining considerations for nucleic acid separation and analysis in agarose gel electrophoresis.
If you’ve worked in a lab, you’ve inevitably had to consider and manage contamination issues. Our guests for this episode are experts at considering and managing situations where the implications of contamination, or lack of containment, move beyond inconvenience to public health and safety risks. Join us for an interesting conversation that will make you think about your work and the responsibilities it brings.
This is the first of the new Mol Bio Minutes, which are mini episodes within this series. In this kickoff episode, Augustė Užuotaitė speaks about migration of different forms of DNA in agarose gel electrophoresis.
Speaking of Mol Bio, a podcast series from Thermo Fisher Scientific, discusses trending applications in science and the molecular biology aspects of those applications. Our host delves in to deep discussion with CEOs, R&D scientists, researchers, and key opinion leaders across the globe. Speaking of Mol Bio helps scientific curious people - from all scientific and non-scientific backgrounds - understand how modern molecular biology applications can help push the boundaries in medicine, science, drug discovery, and in the cure and treatment of diseases.
Music from NOWHERE by ikson™ (https://www.iksonmusic.com)
